全文获取类型
收费全文 | 728篇 |
免费 | 45篇 |
国内免费 | 6篇 |
专业分类
儿科学 | 33篇 |
妇产科学 | 17篇 |
基础医学 | 42篇 |
口腔科学 | 7篇 |
临床医学 | 53篇 |
内科学 | 164篇 |
皮肤病学 | 16篇 |
神经病学 | 30篇 |
特种医学 | 78篇 |
外科学 | 192篇 |
综合类 | 18篇 |
预防医学 | 44篇 |
眼科学 | 15篇 |
药学 | 35篇 |
中国医学 | 1篇 |
肿瘤学 | 34篇 |
出版年
2023年 | 6篇 |
2022年 | 10篇 |
2021年 | 12篇 |
2020年 | 16篇 |
2019年 | 21篇 |
2018年 | 25篇 |
2017年 | 13篇 |
2016年 | 16篇 |
2015年 | 11篇 |
2014年 | 31篇 |
2013年 | 26篇 |
2012年 | 27篇 |
2011年 | 26篇 |
2010年 | 25篇 |
2009年 | 42篇 |
2008年 | 31篇 |
2007年 | 30篇 |
2006年 | 18篇 |
2005年 | 20篇 |
2004年 | 17篇 |
2003年 | 14篇 |
2002年 | 13篇 |
2001年 | 19篇 |
2000年 | 19篇 |
1999年 | 19篇 |
1998年 | 18篇 |
1997年 | 13篇 |
1996年 | 20篇 |
1995年 | 16篇 |
1994年 | 13篇 |
1993年 | 20篇 |
1992年 | 18篇 |
1991年 | 8篇 |
1990年 | 11篇 |
1989年 | 13篇 |
1988年 | 20篇 |
1987年 | 15篇 |
1986年 | 13篇 |
1985年 | 18篇 |
1984年 | 9篇 |
1982年 | 5篇 |
1981年 | 3篇 |
1980年 | 5篇 |
1979年 | 3篇 |
1978年 | 3篇 |
1977年 | 6篇 |
1975年 | 3篇 |
1972年 | 3篇 |
1971年 | 4篇 |
1969年 | 4篇 |
排序方式: 共有779条查询结果,搜索用时 15 毫秒
1.
2.
3.
4.
青蒿琥酯皮肤擦剂在小鼠和兔体内的药代动力学研究 总被引:1,自引:0,他引:1
将青蒿琥酯溶于苯二甲酸二甲酯,加适量氨酮制成皮肤擦剂。给兔脱毛后,皮肤涂抹此擦剂25mg/kg后,血药浓度达峰时间平均为2 h,峰浓度平均为1.80μg/ml。药物在兔体内平均驻留时间为3.54 h,清除半衰期约为2.46 h。给小鼠脱毛皮肤涂抹擦剂6.7,31.3和71.4 mg/kg,血药浓度在给药后0.5~4 h达高峰,峰浓度分别为0.82,2.05和7.11μg/ml,体内药物平均驻留时间为3.39,2.79及3.54 h,清除半衰期为2.35,1.93及2.45 h。可见,给兔及小鼠皮肤擦剂后,青蒿琥酯吸收良好,血药浓度维持时间较长。 相似文献
5.
6.
P Pfitzenmeyer P Foucher F Piard B Coudert M L Braud P Gabez S Lacroix J P Mabille P Camus 《Thorax》1992,47(8):622-627
BACKGROUND: Nilutamide is a new, specific synthetic antiandrogen, released in several countries for the treatment of metastatic carcinoma of the prostate. Eight patients at the University Medical Centre at Dijon and affiliated referring hospitals developed reversible pulmonary opacities and respiratory symptoms while taking the drug. METHODS: Records of eight patients who developed new, otherwise unexplained chest opacities while taking nilutamide were reviewed. In each patient a careful aetiological search was made for other environmental or endogenous causes. Six patients underwent bronchoalveolar lavage, and lavage fluid was cultured. Corticosteroids were not given, unless gas exchange was compromised (two patients). RESULTS: The eight patients (all male) had had carcinoma of the prostate diagnosed on average 10.2 months earlier. All had improved with nilutamide, with a dramatic decrease of prostate specific antigen levels. Seven had received nilutamide at the recommended dosage of 150 mg/day, and one had received twice that amount. Treatment had lasted on average 113 (range 10-225) days, and the mean cumulated exposure was 21.8 (3-38) grams. The chest radiographs showed bilateral infiltrates, with no consistent topographic predilection. A restrictive lung defect was present in six patients and hypoxia in all (mean arterial oxygen tension (PaO2) 6.6 kPa). Bronchoalveolar lavage showed lymphocytosis in four patients and neutrophilia in two. The outcome was favourable in all patients after they had stopped nilutamide only (five patients), with corticosteroids (two patients) or a simple reduction of nilutamide from 300 to 150 mg/day (one patient). Recovery was associated with improvement of pulmonary function and PaO2. CONCLUSION: Nilutamide is associated with interstitial pneumonitis in about 1% of patients and appears reversible. 相似文献
7.
8.
9.
Systemic injection of products of activated neutrophils and H2O2 in myeloperoxidase-immunized rats leads to necrotizing vasculitis in the lungs and gut. 总被引:1,自引:0,他引:1
下载免费PDF全文
![点击此处可从《The American journal of pathology》网站下载免费的PDF全文](/ch/ext_images/free.gif)
P. Heeringa P. Foucher P. A. Klok M. G. Huitema J. W. Tervaert J. J. Weening C. G. Kallenberg 《The American journal of pathology》1997,151(1):131-140
The strong association of anti-neutrophil cytoplasmic antibodies with various forms of systemic vasculitis suggests a role for these autoantibodies in the pathophysiology of systemic vasculitis. In the present study, we tested the hypothesis that release of neutrophil lysosomal enzymes in the presence of an anti-myeloperoxidase (anti-MPO) immune response may underlie the development of systemic vasculitis. Brown Norway rats were immunized with MPO in complete Freund's adjuvant or complete Freund's adjuvant alone. Two weeks after immunization, rats bad developed antibodies to human and rat MPO as measured by enzyme-linked immunosorbent assay. Next, rats were intravenously infused with 400 micrograms of a human neutrophil lysosomal extract containing 200 micrograms of MPO followed by 0.5 ml of a 1 mmol/L solution of H2O2 through a cannula inserted into the right jugular vein. Rats were sacrificed at 4 hours, 24 hours, 7 days, or 14 days, and several organs (lungs, heart, liver, spleen, gut, and kidneys) were examined for vasculitic lesions and inflammatory cell infiltrates. Macroscopically, patchy hemorrhagic spots were observed in the lungs and gut of MPO-immunized rats at days 7 and 14 after systemic infection of the neutrophil lysosomal extract and H2O2. Such changes were not observed at earlier time points or in control immunized rats. Histologically, the lungs of MPO-immunized rats sacrificed at days 7 and 14 showed patchy inflammatory cell infiltrates associated with vasculitis, granuloma formation, giant cells, and foci of hemorrhage. At 14 days, early signs of fibrosis were found with deposition of collagen and proliferation of fibroblasts. Furthermore, a prominent leukocytoclastic vasculitis was found in the small intestine of these rats characterized by fibrinoid necrosis and an extensive neutrophilic infiltrate. No inflammatory changes were found in the other organs studied (heart, liver, spleen, and kidneys). Control immunized rats, sacrificed at days 7 and 14 showed only some small foci of inflammatory infiltrates in the lungs whereas no inflammatory changes were found in the gastrointestinal tract. These studies show that release of products from activated neutrophils in the presence of anti-MPO autoantibodies may be relevant to the pathogenesis of anti-MPO-associated vasculitides. 相似文献
10.